Načítá se...
DiaRem2: Incorporating duration of diabetes to improve prediction of diabetes remission following metabolic surgery
BACKGROUND: DiaRem is a validated tool for predicting the likelihood of type 2 diabetes (T2DM) remission after Roux-en-Y gastric bypass (RYGB) surgery. OBJECTIVES: The objective of this study is to determine if the addition of duration of T2DM to DiaRem improves its ability to discriminate between p...
Uloženo v:
| Vydáno v: | Surg Obes Relat Dis |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589131/ https://ncbi.nlm.nih.gov/pubmed/30686670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.soard.2018.12.020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|